On November 13, ZAI LAB fell 4.38% in Regular Trading, trading at HK$20.1, with turnover of HK$19.14 million.

The immediate catalyst was the company’s November 12 disclosure that it issued a total of about 7.1 million new shares under its share plan, prompting market attention to near-term dilution.

The filing showed roughly 6.30 million shares were issued to participants and about 0.80 million shares to directors, equal to about 0.56% of issued share capital at the time, with an issue price of HK$0 per share. After completion, total issued shares increased from about 1.251 billion as of October 31 to about 1.258 billion. The move follows recent equity financing and came shortly after the company reported third-quarter revenue of US$108.2 million, including net product revenue of US$107.6 million, while investors appeared focused on share count expansion rather than operating updates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)